BNO 0.00% 1.0¢ bionomics limited

Ann: Strategic Review Outcome and Program Updates, page-4

  1. 1,384 Posts.
    lightbulb Created with Sketch. 283
    "Patient enrolment in BNC210 exploratory clinical trial to treat Agitation in elderly patients in a hospital/nursing home setting is now complete and top line data are expected by the end of June 2019."

    That's all I needed to hear.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.